Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Ameridose, LLC
483
•Ameridose, LLC•August 6, 2008

Ameridose, LLC – FDA 483, Aug 6, 2008

Record Details

The FDA Form 483 inspection revealed several deficiencies in the firm's manufacturing and quality control processes.

**Key Violations and Observations:**

* **Drug Product Release without Complete Testing:** The firm releases finished drug products (e.g., Fentanyl/Bupivacaine, Sufentanil/Ropivacaine, Oxytocin) for distribution immediately after manufacturing, without performing potency or identity tests on the finished product. Products are shipped before sterility test results are received, despite SOP 9.060 stating products "shall be released on by the quarantine Pharmacist" due to limited Beyond Use dating. * **Inadequate Component Control Procedures:** Written procedures (SOP 5.010) lack sufficient detail for the identification, sampling, and testing of received Active Pharmaceutical Ingredients (APIs). While Certificates of Analysis are received and initial lots validated, not all API lots undergo specific identity testing using USP methods or validated equivalent methods (e.g., Hydromorphone HCL, Ropivacaine). * **Deficient Master Production Records:** Master Production Records (Master Formula Worksheets) do not include theoretical yield statements or minimum/maximum yield percentages (e.g., Fentanyl stock solution, Oxytocin stock solution). * **Incomplete Batch Production Records:** Batch Formula Worksheets for stock solutions and finished products lack documentation of line clearance inspections of packaging and labeling areas before and after use (e.g.,

Company
Ameridose, LLC
Inspection date
August 6, 2008
Product type
Drugs
Office
New England District Office
View Company Profile

ID · c13bd69c-7466-4a36-bb8e-61caa02be437

Violation Codes3
21 CFR 21021 CFR 21121 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Ameridose, LLC
  • 483 - 2012-11-09November 9, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ameridose, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.